IOLCPPharmaceuticals
IOL Chemicals and Pharmaceuticals Ltd — Balance Sheet
₹72.77
-0.81%
IOL Chemicals and Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 29.35 Cr | 29.35 Cr | 29.35 Cr | 29.35 Cr | — |
| Share Issued | 29.35 Cr | 29.35 Cr | 29.35 Cr | 29.35 Cr | — |
| Net Debt | 38.87 Cr | 25.07 Cr | 78.24 Cr | 39.52 Cr | — |
| Total Debt | 117.04 Cr | 32.76 Cr | 79.81 Cr | 43.95 Cr | — |
| Tangible Book Value | 1.67K Cr | 1.60K Cr | 1.50K Cr | 1.39K Cr | — |
| Invested Capital | 1.80K Cr | 1.64K Cr | 1.59K Cr | 1.44K Cr | — |
| Working Capital | 541.43 Cr | 559.77 Cr | 464.13 Cr | 567.42 Cr | — |
| Net Tangible Assets | 1.67K Cr | 1.60K Cr | 1.50K Cr | 1.39K Cr | — |
| Capital Lease Obligations | 0.00 | 0.00 | 0.18 Cr | 1.20 Cr | — |
| Common Stock Equity | 1.69K Cr | 1.61K Cr | 1.51K Cr | 1.39K Cr | — |
| Total Capitalization | 1.69K Cr | 1.61K Cr | 1.51K Cr | 1.39K Cr | — |
| Total Equity Gross Minority Interest | 1.69K Cr | 1.61K Cr | 1.51K Cr | 1.39K Cr | — |
| Stockholders Equity | 1.69K Cr | 1.61K Cr | 1.51K Cr | 1.39K Cr | — |
| Other Equity Interest | 1.63K Cr | 1.55K Cr | 1.45K Cr | 1.33K Cr | — |
| Retained Earnings | 1.40K Cr | 1.32K Cr | 1.22K Cr | 1.10K Cr | — |
| Additional Paid In Capital | 225.72 Cr | 225.72 Cr | 225.72 Cr | 225.72 Cr | — |
| Capital Stock | 58.71 Cr | 58.71 Cr | 58.71 Cr | 58.71 Cr | — |
| Common Stock | 58.71 Cr | 58.71 Cr | 58.71 Cr | 58.71 Cr | — |
| Total Liabilities Net Minority Interest | 694.41 Cr | 632.89 Cr | 514.41 Cr | 569.82 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 84.50 Cr | 72.89 Cr | 58.15 Cr | 56.42 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 6.69 Cr | 6.71 Cr | 1.65 Cr | — | 3.68 Cr |
| Non Current Deferred Taxes Liabilities | 77.81 Cr | 66.14 Cr | 56.36 Cr | 53.18 Cr | — |
| Long Term Debt And Capital Lease Obligation | 0.00 | 0.00 | 0.00 | 0.18 Cr | — |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Provisions | 6.69 Cr | 6.71 Cr | 1.65 Cr | 3.01 Cr | — |
| Current Liabilities | 609.91 Cr | 560.00 Cr | 456.26 Cr | 513.40 Cr | — |
| Other Current Liabilities | 19.98 Cr | 23.58 Cr | 17.04 Cr | 21.13 Cr | — |
| Current Debt And Capital Lease Obligation | 117.04 Cr | 32.76 Cr | 79.81 Cr | 43.77 Cr | — |
| Current Capital Lease Obligation | 0.00 | 0.00 | 0.18 Cr | 1.02 Cr | — |
| Current Debt | 117.04 Cr | 32.76 Cr | 79.63 Cr | 42.75 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 1.97 Cr | 3.39 Cr | 8.13 Cr | 7.34 Cr | — |
| Current Provisions | 1.97 Cr | 3.39 Cr | 8.13 Cr | 7.34 Cr | — |
| Payables | 457.63 Cr | 491.42 Cr | 343.84 Cr | 427.09 Cr | — |
| Other Payable | 28.81 Cr | 21.12 Cr | 28.72 Cr | 17.09 Cr | — |
| Dividends Payable | 1.26 Cr | 1.12 Cr | 0.90 Cr | 0.71 Cr | — |
| Accounts Payable | 427.56 Cr | 469.18 Cr | 314.22 Cr | 409.29 Cr | — |
| Total Assets | 2.38K Cr | 2.24K Cr | 2.02K Cr | 1.96K Cr | — |
| Total Non Current Assets | 1.23K Cr | 1.12K Cr | 1.10K Cr | 881.48 Cr | — |
| Other Non Current Assets | 12.80 Cr | 24.35 Cr | 9.01 Cr | 10.30 Cr | — |
| Non Current Prepaid Assets | 9.14 Cr | 9.09 Cr | 6.90 Cr | 6.61 Cr | — |
| Investmentin Financial Assets | 24.35 Cr | 46.51 Cr | 204.07 Cr | 185.06 Cr | — |
| Available For Sale Securities | 24.35 Cr | 46.51 Cr | 204.07 Cr | 185.06 Cr | — |
| Goodwill And Other Intangible Assets | 13.60 Cr | 12.75 Cr | 9.04 Cr | 3.55 Cr | — |
| Other Intangible Assets | 13.60 Cr | 12.75 Cr | 9.04 Cr | 3.55 Cr | — |
| Net PPE | 1.18K Cr | 1.04K Cr | 835.39 Cr | 666.80 Cr | — |
| Accumulated Depreciation | -370.12 Cr | -301.03 Cr | -242.47 Cr | -201.52 Cr | — |
| Gross PPE | 1.55K Cr | 1.34K Cr | 1.08K Cr | 868.32 Cr | — |
| Construction In Progress | 24.33 Cr | 114.95 Cr | 84.23 Cr | 106.34 Cr | — |
| Other Properties | 0.53 Cr | 0.67 Cr | 1.50 Cr | 2.40 Cr | — |
| Machinery Furniture Equipment | 1.16K Cr | 932.03 Cr | 784.80 Cr | 603.42 Cr | — |
| Buildings And Improvements | 211.29 Cr | 148.65 Cr | 136.89 Cr | 100.09 Cr | — |
| Land And Improvements | 160.09 Cr | 141.24 Cr | 70.44 Cr | 56.07 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 1.15K Cr | 1.12K Cr | 920.39 Cr | 1.08K Cr | — |
| Other Current Assets | 59.61 Cr | -0.59 Cr | 41.07 Cr | 34.88 Cr | — |
| Hedging Assets Current | 0.00 | 0.60 Cr | 0.25 Cr | 0.32 Cr | — |
| Restricted Cash | 49.25 Cr | 30.72 Cr | 5.75 Cr | 86.38 Cr | — |
| Prepaid Assets | 44.99 Cr | 58.71 Cr | 41.07 Cr | 34.32 Cr | — |
| Inventory | 360.62 Cr | 424.84 Cr | 325.52 Cr | 409.89 Cr | — |
| Finished Goods | 137.67 Cr | 164.95 Cr | 109.70 Cr | 92.75 Cr | — |
| Work In Process | 38.62 Cr | 44.85 Cr | 61.85 Cr | 59.70 Cr | — |
| Raw Materials | 184.33 Cr | 215.04 Cr | 153.97 Cr | 257.44 Cr | — |
| Other Receivables | 20.25 Cr | 11.86 Cr | 22.13 Cr | 22.66 Cr | — |
| Taxes Receivable | 0.34 Cr | 6.76 Cr | 1.75 Cr | 0.91 Cr | — |
| Accounts Receivable | 513.69 Cr | 471.23 Cr | 505.28 Cr | 469.80 Cr | — |
| Allowance For Doubtful Accounts Receivable | -2.63 Cr | -1.65 Cr | -1.41 Cr | -1.39 Cr | — |
| Gross Accounts Receivable | 516.32 Cr | 472.88 Cr | 506.69 Cr | 471.19 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 162.20 Cr | 115.05 Cr | 18.64 Cr | 55.98 Cr | — |
| Other Short Term Investments | 84.03 Cr | 107.36 Cr | 17.25 Cr | 52.75 Cr | — |
| Cash And Cash Equivalents | 78.17 Cr | 7.69 Cr | 1.39 Cr | 3.23 Cr | — |
| Cash Financial | 78.17 Cr | 7.69 Cr | 1.39 Cr | 3.23 Cr | — |
| Other Non Current Liabilities | — | 0.04 Cr | 0.14 Cr | 0.05 Cr | 0.38 Cr |
| Long Term Capital Lease Obligation | — | 0.00 | 0.00 | 0.18 Cr | 1.83 Cr |
| Assets Held For Sale Current | — | — | 0.00 | 0.56 Cr | — |
| Cash Equivalents | — | — | — | 0.00 | 15.03 Cr |
| Non Current Deferred Revenue | — | — | — | — | 0.38 Cr |
| Current Deferred Taxes Liabilities | — | — | — | — | 4.66 Cr |
| Total Tax Payable | — | — | — | — | 4.66 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on IOL Chemicals and Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.